Patents by Inventor Zaid AMSO

Zaid AMSO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • LONG-ACTING DUAL GIP/GLP-1 PEPTIDE CONJUGATES AND METHODS OF USE
    Publication number: 20240148884
    Abstract: Provided herein are peptides and peptide conjugates comprising a dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist. The peptides may be used for blood glucose management and treating conditions such as diabetes, obesity, non-alcoholic fatty liver disease (NAFLD), and non-alcoholic steatohepatitis (NASH).
    Type: Application
    Filed: August 7, 2023
    Publication date: May 9, 2024
    Inventors: Weijun SHEN, Zaid AMSO, Peter G. Schultz
  • PEPTIDE CONJUGATES AND METHODS OF USE
    Publication number: 20230071371
    Abstract: Peptide conjugates comprising a peptide selected from a peptide that modulates the PYY receptor, a peptide that modulates both the GLP-1 receptor and the GCG receptor, a peptide that modulates both the GLP-1 receptor and the GIP receptor, and a peptide that modulates the GLP-1 receptor; and a staple attached to the peptide at a first amino acid and a second amino acid are disclosed herein. Also provided are peptide conjugates comprising prolactin-releasing peptide. The peptide conjugates may be used for treating conditions such as obesity. Further provided are stapled prolactin-releasing peptide.
    Type: Application
    Filed: December 3, 2020
    Publication date: March 9, 2023
    Inventors: Weijun SHEN, Elsa PFLIMLIN, Sam LEAR, Zaid AMSO, Peter G. SCHULTZ
  • GLP2 RECEPTOR AGONISTS AND METHODS OF USE
    Publication number: 20230057847
    Abstract: Peptide conjugates comprising a peptide that modulates the GLP-2 receptor are provided. The peptide conjugates may be used for treating conditions responsive to modulation of the GLP-2 receptor. Further provided are stapled GLP-2 peptide conjugates.
    Type: Application
    Filed: December 3, 2020
    Publication date: February 23, 2023
    Inventors: Weijun SHEN, Peter G. SCHULTZ, Zaid AMSO